Department of Hepatology, Norfolk and Norwich University Hospitals NHS Trust, Norwich, UK.
Division of Pathology, University of Edinburgh, Edinburgh, UK.
Gut. 2023 Dec 7;73(1):16-46. doi: 10.1136/gutjnl-2023-330029.
These guidelines for the diagnosis and management of cholangiocarcinoma (CCA) were commissioned by the British Society of Gastroenterology liver section. The guideline writing committee included a multidisciplinary team of experts from various specialties involved in the management of CCA, as well as patient/public representatives from AMMF (the Cholangiocarcinoma Charity) and PSC Support. Quality of evidence is presented using the Appraisal of Guidelines for Research and Evaluation (AGREE II) format. The recommendations arising are to be used as guidance rather than as a strict protocol-based reference, as the management of patients with CCA is often complex and always requires individual patient-centred considerations.
本胆管癌（CCA）诊断和管理指南由英国胃肠病学学会肝脏分会委托制定。指南写作委员会由来自多个专业领域的多学科专家团队组成，涉及 CCA 的管理，以及来自 AMMF（胆管癌慈善机构）和 PSC 支持组织的患者/公众代表。证据质量使用评估指南研究与评价（AGREE II）格式呈现。提出的建议旨在作为指导，而不是严格的基于协议的参考，因为 CCA 患者的管理通常很复杂，始终需要考虑到每个患者的具体情况。
